Food and Drug Administration (FDA)

The NWHN is Disappointed in the 5th Circuit Court’s Decision Regarding Mifepristone

By NWHN Staff | Aug 16, 2023 | Comments Off on The NWHN is Disappointed in the 5th Circuit Court’s Decision Regarding Mifepristone

Although the 5th Circuit Court’s decision does not go as far as anti-abortion advocates might have hoped, it is still a grave threat to abortion access.

The NWHN Applauds the FDA’s Decision to Make a Birth Control Pill Available Over-the-Counter

By Carter Ringo | Jul 13, 2023 | Comments Off on The NWHN Applauds the FDA’s Decision to Make a Birth Control Pill Available Over-the-Counter

OPill is the first over-the-counter birth control pill available in the U.S. It is safe, effective, and will increase access to contraception for millions of women nationwide.

020: How the FDA Works and How Advocates Work With It with Kirsten Moore

By Carter Ringo | Jun 1, 2023 | Comments Off on 020: How the FDA Works and How Advocates Work With It with Kirsten Moore

—

The NWHN’s Written Testimony to the FDA Regarding Over-The-Counter Authorization of Opill, an Oral Contraceptive

By Carter Ringo | May 2, 2023 | Comments Off on The NWHN’s Written Testimony to the FDA Regarding Over-The-Counter Authorization of Opill, an Oral Contraceptive

Read the NWHN’s testimony to the FDA in support of OPILL, an oral contraceptive, being approved for over-the-counter dispensation.

Everything You Need to Know About Mifepristone, Medication Abortion Access, and the Case Working Its Way Through the Courts Right Now

By Kristen Batstone | Apr 26, 2023 | Comments Off on Everything You Need to Know About Mifepristone, Medication Abortion Access, and the Case Working Its Way Through the Courts Right Now

~~~

A Statement on the Supreme Court’s Mifepristone Decision

By NWHN Staff | Apr 21, 2023 | Comments Off on A Statement on the Supreme Court’s Mifepristone Decision

The National Women’s Health Network applauds the Supreme Court for its decision to block the lower court’s ruling against Mifepristone, one of two medication abortion drugs, until the end of the legal proceedings.

It’s Time to #MailTheAbortionPill

By Sarah Christopherson | Jul 1, 2020 | Comments Off on It’s Time to #MailTheAbortionPill

Patients are turning to telehealth appointments and online pharmacies for routine medical care during the COVID-19 outbreak without having to leave their homes. But for most pregnant people seeking safe and effective abortion pills, the FDA has created a Byzantine set of rules that delay or block access to care.

Three Things You Should Know About Scott Gottlieb – Trump’s FDA Commissioner Nominee!

By NWHN Staff | Apr 2, 2017 | Comments Off on Three Things You Should Know About Scott Gottlieb – Trump’s FDA Commissioner Nominee!

This Wednesday, the Senate Committee on Health, Education, Labor and Pensions (HELP) will consider the nomination of Dr. Scott Gottlieb to head the Food and Drug Administration (FDA).

R.E.S.P.E.C.T.: What Women Need From the New FDA Commissioner

By Cindy Pearson | Mar 15, 2017 | Comments Off on R.E.S.P.E.C.T.: What Women Need From the New FDA Commissioner

Okay, I admit it. Sometimes I try to cheer myself up by turning on some upbeat music and dancing by myself. Although I wouldn’t want anyone to see me bouncing around when I’ve cranked up the music (I’m a lousy dancer), I don’t mind people knowing that one of my favorite cheer-me-up songs is Aretha Franklin’s version of “RESPECT.”